Altoida develops and markets a healthcare platform and application for Alzheimer’s patients. Altoida Medical Device (AMD) is a class II medical device to screen and monitor cognitive outcomes. It supports neurologists to classify patients healthy, at risk, and with Mild Cognitive Impairment (MCI) as a digital biomarker.
Type | Private | |
Founded | 2016 | |
HQ | Luzern, CH | Map |
Website | altoida.com |
Employees (est.) (Feb 2021) | 13 | (+9%) |
Cybersecurity rating | A | More |
Founding Date | 2016 |
Altoida total Funding | $7.5 m |
Time since last funding | 10 months ago |
Altoida investors | Polytech Ventures, Philipp Stauffer, Fyrfly Venture Partners, Hikma Ventures, Grey Sky Venture Partners, M Ventures, Adrian Locher, VI Partners AG, Alpana Ventures |
Altoida has 259 Twitter Followers. The number of followers has increased 2.3% month over month and increased 4.5% quarter over quarter
When was Altoida founded?
Altoida was founded in 2016.
Who are Altoida key executives?
Altoida's key executives are Richard Fischer, Ioannis Tarnanas and Maximilian Buegler.
How many employees does Altoida have?
Altoida has 13 employees.
Who are Altoida competitors?
Competitors of Altoida include Bodycad, OptimizeRx and Nano.
Where is Altoida headquarters?
Altoida headquarters is located at Professuren der Kultur-und Sozialwissenschaftlichen Fakultät 31 Hirschengraben, Luzern.
Where are Altoida offices?
Altoida has offices in Luzern and Suwanee.
How many offices does Altoida have?
Altoida has 2 offices.
Receive alerts for 300+ data fields across thousands of companies